Overview

Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)

Status:
Unknown status

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

It is a trials to evaluate the overall survival (OS) of radiotherapy / EP combined with recombinant human endostatin in treatment of locally advanced (Ⅲ A / unresectable Ⅲ B) non-small cell lung cancer.

Phase:

Phase 4

Details

Lead Sponsor:

Simcere Pharmaceutical Co., Ltd

Collaborator:

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Treatments:

Endostatins